Work

1726MO Updated efficacy and safety of botensilimab plus balstilimab in patients with refractory metastatic sarcoma from an expanded phase I study

Year: 2024

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2024.08.1818

Authors: B.A. Wilky, J.C. Trent, A.M. Tsimberidou, M. Gordon, A.B. El-Khoueiry, A. Bullock, B.S. Henick, M. Agulnik, D. Mahadevan, A. Singh, W. Wu, M. Avagyan, J.M. Patel, J. Grossman, S.J. O'Day, G. Schwartz, R.L. Jones

Institutions: University of Colorado Health, University of Colorado Cancer Center, University of Colorado Anschutz, Sylvester Comprehensive Cancer Center, The University of Texas MD Anderson Cancer Center, HonorHealth, University of Southern California, Beth Israel Deaconess Medical Center, NewYork–Presbyterian Hospital, Columbia University Irving Medical Center, City Of Hope National Medical Center, City of Hope, The University of Texas at San Antonio Health Science Center, University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center, Agenus (United States), Case Comprehensive Cancer Center, Institute of Cancer Research, Royal Marsden Hospital

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Meso Scale Diagnostics

OpenAlex ID: W4402704870

FWCI: 0.29

Cites:

Cited by: 1

Related to: 10